GCNT1 and prostate carcinoma: Of particular interest, when GCNT1 is highly expressed in primary prostate cancer tissue there is significant enrichment of the hallmark pathway ‘G2M checkpoint’, which is associated with the trajectory of prostate cancer progression38 (NES 1.94, FDR q value 1.6e−02) (Fig. 1F).